Fulgent Genetics Inc (FLGT)
Debt-to-capital ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 1,133,230 | 1,138,440 | 1,132,550 | 1,129,940 | 1,136,100 | 1,258,700 | 1,259,760 | 1,268,920 | 1,269,880 | 1,281,400 | 1,304,760 | 1,312,960 | 1,165,880 | 1,036,780 | 920,725 | 801,566 | 569,387 | 186,955 | 87,043 | 81,372 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $1,133,230K)
= 0.00
The debt-to-capital ratio of Fulgent Genetics Inc has consistently remained at 0.00% for all the quarters reported from March 31, 2020 to December 31, 2024. This indicates that the company has not utilized any debt to finance its operations or growth during this period. A debt-to-capital ratio of 0.00% suggests that the company's capital structure is primarily equity-based, pointing towards a lower financial risk profile as there is no debt to service. Investors and creditors may view this ratio positively as it signifies financial stability and lower leverage, potentially enhancing the company's creditworthiness and solvency.
Peer comparison
Dec 31, 2024